Clearside Biomedical, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $5.13 | $320.64 M | -1.97 | 145 | $20.76 M |
 DRTS
|
Alpha Tau Medical Ltd. | $2.20 | $170.30 M | -5.95 | 121 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $7.51 | $217.51 M | -3.7 | 54 | $0 |
 EPIX
|
ESSA Pharma Inc. | $1.79 | $253.76 M | -9.08 | 50 | $0 |
 ERAS
|
Erasca, Inc. | $2.85 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $33.23 | $1.65 B | -11.47 | 108 | $0 |
 EYEN
|
Eyenovia, Inc. | $0.41 | $40.94 M | -1.03 | 57 | $3,787 |
 GBIO
|
Generation Bio Co. | $1.83 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.63 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 GRPH
|
Graphite Bio, Inc. | $3.18 | $185.19 M | -0.21 | 6 | $0 |
 INBX
|
Inhibrx Biosciences, Inc. | $15.45 | $241.02 M | -1.44 | 166 | $1.80 M |
 INZY
|
Inozyme Pharma, Inc. | $3.56 | $286.39 M | -3.43 | 59 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.89 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYRA
|
Lyra Therapeutics, Inc. | $0.20 | $19.53 M | -0.27 | 88 | $1.56 M |
 MACK
|
Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 |
 NUVB
|
Nuvation Bio Inc. | $2.95 | $684.66 M | -8.66 | 203 | $0 |
 NXTC
|
NextCure, Inc. | $1.43 | $38.88 M | -0.61 | 82 | $0 |
 OCUL
|
Ocular Therapeutix, Inc. | $10.60 | $765.15 M | -4.41 | 267 | $58.44 M |
 ORIC
|
ORIC Pharmaceuticals, Inc. | $10.27 | $595.34 M | -4.91 | 100 | $0 |
 PNT
|
POINT Biopharma Global Inc. | $12.50 | $1.33 B | 11.36 | 129 | $226.58 M |
 SNSE
|
Sensei Biotherapeutics, Inc. | $0.54 | $16.31 M | -0.54 | 28 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 TNYA
|
Tenaya Therapeutics, Inc. | $2.09 | $285.80 M | -2.21 | 140 | $0 |